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Abstract
Arylazido-L-alanine ADP-ribose, a photoreactive analogue of ADP-ribose, was synthesized. In the dark, arylazido-L-
alanine ADP-ribose acts as a competitive reversible inhibitor of mitochondrial NADH-ubiquinone reductase with a Ki of 37
WM. Upon photolysis, arylazido-L-alanine ADP-ribose is converted to a potent irreversible active site-directed inhibitor of
the enzyme. Photo-induced inhibition of membrane-bound NADH-ubiquinone reductase by arylazido-L-alanine ADP-ribose
is incomplete and results in a 20-fold reduction of the NADH oxidase and 2.5-fold reduction of the energy-dependent NAD
reductase activities. The arylazido-L-alanine ADP-ribose resistant activities (direct and reverse) of the enzyme are
characterized by a two orders of magnitude lower affinity to the corresponding substrates compared to those of the
uninhibited NADH-ubiquinone reductase. A different kinetic behavior of the inhibited and native enzyme can be explained
by invoking the two catalytically competent nucleotide-binding sites model of NADH-ubiquinone reductase. ß 1999
Elsevier Science B.V. All rights reserved.
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1. Introduction
NADH-ubiquinone reductase (EC 1.6.5.3), com-
monly known as complex I, catalyzes electron trans-
fer from NADH to ubiquinone and couples this
process to proton translocation across the inner mi-
tochondrial membrane. The isolated mitochondrial
enzyme is composed of more than 40 individual sub-
units [1,2] and contains at least ¢ve iron-sulfur cen-
ters, a £avin mononucleotide moiety and tightly
bound ubiquinone molecules, which participate in
electron transfer from NADH to ubiquinone. De-
spite growing interest in the subject and an increased
number of recent publications devoted to complex I,
the catalytical mechanism of the enzyme is still far
from being understood. Neither the sequence of in-
tramolecular electron transfer reactions leading elec-
trons from NADH to ubiquinone nor the number of
the substrate-binding sites on the enzyme are known.
A wide variety of compounds are known to inhibit
the NADH-ubiquinone reductase activity of the mi-
tochondrial complex I. They are represented by a
large number of non-competitive inhibitors, which
act at or close to the ubiquinone reduction site [3^
5], and a few competitive inhibitors that act at the
nucleotide-binding site of the enzyme. The latter
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class of inhibitors includes AMP, ADP, ATP [6] and
NAD [7,8], characterized by a low a⁄nity to the
enzyme, and ADP-ribose [9], as recently discovered
by Vinogradov and coworkers, having a relatively
high a⁄nity to the active center of complex I.
Previous studies by Chen and Guillory [10] have
shown that the arylazido-L-alanine analogue of
NAD acts as a competitive inhibitor of NADH-
ubiquinone reductase in the dark. Light irradiation
results in photo-dependent irreversible attachment of
the analogue to the enzyme. The use of arylazido-L-
alanine NAD for studies of the catalytical mecha-
nism of complex I was limited by insu⁄cient a⁄nity
of the NAD analogue to the enzyme. The insu⁄-
cient a⁄nity of the inhibitor leads to multi-site label-
ling of complex I and to a mixed type (competitive
plus non-competitive) inhibition of its NADH-ubi-
quinone reductase activity [10].
The present communication describes the proce-
dure for preparation of arylazido-L-alanine ADP-ri-
bose, a strong competitive inhibitor of the mitochon-
drial NADH-ubiquinone oxidoreductase. The e¡ect
of arylazido-L-alanine ADP-ribose on NADH oxi-
dase and on energy-dependent NAD reductase ac-
tivities of membrane-bound complex I has been in-
vestigated.
2. Materials and methods
All chemicals were obtained from Sigma Chemical
Company.
2.1. Synthesis and puri¢cation of arylazido-L-alanine
NAD+
Arylazido-L-alanine NAD was synthesized from
arylazido-L-alanine and NAD essentially as de-
scribed by Chen and Guillory [10]. The mixture of
products obtained after the synthesis, containing
arylazido-L-alanine adducts and free NAD, was dis-
solved in 20 ml water. The pH of the solution was
brought to 5.5 by addition of KOH. The solution
was loaded onto a 100U10 mm DEAE-Sephadex
column equilibrated with 5 mM Tris-HCl (pH 7.5).
Arylazido-L-alanine NAD and co-products of the
synthesis were eluted from the column at 25‡C with
5 mM Tris-HCl (pH 7.5) at a £ow rate of 0.5 ml/min
by a linear KCl gradient from 0 to 1 M over a period
of 2 h. Arylazido-L-alanine NAD elutes from the
column at 0.15 M KCl. Chromatography on a
DEAE column enabled complete puri¢cation of aryl-
azido-L-alanine NAD from arylazido-L-alanine
containing co-products of the synthesis and free aryl-
azido-L-alanine. The latter compounds were eluted
from the column in KCl concentrations higher than
0.2 M. Arylazido-L-alanine NAD fractions eluted
from the DEAE column contained free NAD. Fur-
ther chromatography of the compound on a C-4 re-
versed-phase high performance liquid chromatogra-
phy column, 250U4.6 mm (Vydac, Hesperia, CA,
USA), enabled separation of the labelled dinucleo-
tide from the unlabelled one. The unlabelled dinu-
cleotide was eluted from the column in 5 mM
CH3COONa (pH 5.5) at a £ow rate of 0.8 ml/min,
while arylazido-L-alanine NAD was eluted from the
column in 50% methanol. Methanol was removed
from arylazido-L-alanine NAD by chromatography
of the latter on DEAE-Sephacell. Arylazido-L-ala-
nine NAD, eluted from C-4 column, was diluted
¢ve times with water and loaded onto a 100U10
mm DEAE-Sephacell column equilibrated with
5 mM CH3COONa (pH 5.5). The labelled dinucleo-
tide was eluted from the column in 200 mM KCl. The
relative absorbance ratio of the puri¢ed arylazido-L-
alanine NAD at 260 and 475 nm is equal to 8.3.
2.2. Photolysis
Submitochondrial particles (SMPs) were diluted
with 50 mM Tris-Cl (pH 8.0), mixed with arylazido-
L-alanine ADP-ribose and irradiated by a TM-36
transilluminator (UVP, San Gabriel, CA, USA) in
a glass microcuvette. The short UV light generated
by the transilluminator was completely ¢ltered by the
glass wall of the cuvette and the sample was irradi-
ated mostly by 320^350 nm light. Irradiation of
SMPs in the absence of arylazido-L-alanine ADP-ri-
bose did not result in complex I inactivation.
2.3. Enzyme assay
SMPs were prepared and coupled with oligomycin
as described [11]. The protein content was deter-
mined with Biuret reagent. NADH oxidase and
NAD reductase activities were measured at 25‡C
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in 1 ml of assay solution containing 0.25 M sucrose,
0.1 mM EDTA, 20 mM Tris-Cl (pH 8.0) and 1 mg/
ml bovine serum albumin (BSA). NADH oxidase
reaction was initiated by addition of 7 Wg SMP to
the assay solution supplemented with 100 WM
NADH. NADH-ferricyanide reductase reaction was
initiated by addition of 7 Wg SMP to the assay solu-
tion supplemented with 1 mM ferricyanide, 100 WM
NADH and 1 mM KCN. NADH-ubiquinone reduc-
tase was initiated by addition of 3 Wg SMP to the
assay mixture supplemented with 20 WM 2,3-dimeth-
oxy-5-methyl-6-decylbenzoquinone, 100 WM NADH,
1 mM KCN and 0.4 Wg/ml gramicidin. The
succinate-supported NAD reductase reaction was
initiated by simultaneous addition of 2 mM NAD
and 20 mM succinate-K to the assay solution
containing 14 Wg/ml SMP. NADPH oxidase reaction
was measured at 25‡C in a 0.4 ml microcuvette (0.2
cm optical path). The reaction was initiated by addi-
tion of 10 Wg SMP to 0.4 ml of the assay solution
containing 0.25 M sucrose, 100 mM Na-Pi (pH 6.0),
1 mg/ml BSA, 0.5 mM NADPH and 0.4 Wg/ml gra-
micidin. SMPs were pretreated with butanedione as
described [12] in order to suppress transhydrogenase
activity. The initial rates of NAD(P)H oxidation or
NAD reduction were followed at 340 nm
(OmM = 6.2).
3. Results
3.1. Preparation of arylazido-L-alanine ADP-ribose
We have used chromatographically puri¢ed aryl-
azido-L-alanine NAD as a starting material for
preparation of arylazido-L-alanine ADP-ribose. Aryl-
azido-L-alanine NAD prepared as described in Sec-
tion 2 is characterized by absorption maxima at 475
and 260 nm. The relative absorbance ratio at 260 and
475 nm of arylazido-L-alanine NAD obtained in
this work is equal to 8.3. This value is higher than
the value of 7.6 reported earlier by Chen and Guil-
lory [10]. The probable reason for the di¡erence in
the absorbance ratios for arylazido-L-alanine NAD
obtained in this and in the earlier studies is a higher
puri¢cation level of the compound achieved in the
present work by column chromatography.
Chromatographically puri¢ed arylazido-L-alanine
NAD was subjected to enzymatic hydrolysis with
NAD glycohydrolase (NADase) (EC 3.2.2.5). Enzy-
matic hydrolysis of arylazido-L-alanine NAD re-
sults in two products: nicotinamide and arylazido-
L-alanine ADP-ribose. The positively charged nico-
Fig. 1. Chromatography of NADase-treated arylazido-L-alanine
NAD on DEAE-Sephacel. Arylazido-L-alanine NAD (1.3
mM) was treated with NADase (0.02 U/ml) at 37‡C in 20 mM
HEPES (pH 7.0). One ml of 1.3 mM arylazido-L-alanine
NAD solution before (solid line) and after 30 min hydrolysis
with NADase (dotted line) was loaded onto a 100U10 mm
DEAE-Sephacell column equilibrated with 5 mM CH3COONa
(pH 5.5) and was eluted by KCl. The arrows indicate addition
of 0.05 and 0.5 M KCl to the column bu¡er.
Fig. 2. Competitive inhibition of the NADH oxidase by arylaz-
ido-L-alanine ADP-ribose. The initial rate of NADH oxidation
(V) was measured as described in Section 2 in the presence of
0.5 (curve 1), 1 (curve 2), 1.5 (curve 3), 2.5 (curve 4) and 3.5
WM NADH (curve 5). The dependences of initial rates of the
reaction on the concentration of arylazido-L-alanine ADP-ri-
bose are presented in Dixon coordinates. V is expressed in
Wmol NADH oxidized per min per mg protein.
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tinamide elutes from a DEAE column in void volume.
Arylazido-L-alanine ADP-ribose, carrying a charge of
32, elutes from the column at higher salt concentra-
tions than the non-hydrolyzed arylazido-L-alanine
NAD, carrying a charge of 31 (see Fig. 1). Aryl-
azido-L-alanine ADP-ribose obtained by the above
procedure has characteristic absorption maxima at
475 and 260 nm. The ratio of absorbances of the
compound at 260 and 475 nm is equal to 7.5, a value
which is less than the value (8.3) estimated in this
work for arylazido-L-alanine NAD. The di¡erence
in the relative absorbances of both compounds at
260 nm corresponds to the contribution of the nic-
otinamide group to the net absorbance of arylazido-
L-alanine NAD at this wavelength.
3.2. Inhibition of NADH-ubiquinone reductase by
arylazido-L-alanine ADP-ribose
Fig. 2 depicts a kinetic analysis of reversible inhibi-
tion of NADH oxidase activity of SMPs in the dark
by arylazido-L-alanine ADP-ribose in Dixon plots.
As evident from the ¢gure, arylazido-L-alanine
ADP-ribose acts as a competitive inhibitor of the
enzyme with a Ki value of 37 þ 5 WM. The a⁄nity
of arylazido-L-alanine ADP-ribose to the enzyme is
much higher than that of arylazido-L-alanine NAD.
The latter had no e¡ect on the rate of NADH oxi-
Fig. 3. Light-induced irreversible inhibition of complex I by
arylazido-L-alanine ADP-ribose. A: SMPs (0.5 mg/ml) were
placed in a 1 mm path glass microcuvette and irradiated (see
Section 2) for the time indicated on the ¢gure in the presence
of 10 (curve 1), 20 (curve 2), 30 (curve 3), 40 (curve 4), 50
(curve 5) and 50 WM arylazido-L-alanine ADP-ribose plus 10
mM ADP-ribose (curve 6). The power of the excitation light
was 8-fold reduced by a neutral density ¢lter. NADH-ferricya-
nide reductase activity of the irradiated particles was measured
as described in Section 2. One hundred percent activity corre-
sponds to 9.5 Wmol NADH oxidized per min per mg protein.
The continuous curves are single exponential best-¢t approxi-
mations of the experimental data. B: The dependence of the
rate constant (k) of photo-inactivation on the arylazido-L-ala-
nine ADP-ribose concentration. The rate constants were esti-
mated from single exponential analysis on A. The solid curve is
a best-¢t hyperbolic approximation of the dependence of the
rate constant on the inhibitor concentration. The values of kmax
and Ki (the inhibitor concentration at which k is equal to half
of kmax) are correspondingly equal to 0.076 s31 and 35 WM and
were obtained from the hyperbolic ¢tting.
Fig. 4. Inhibition of NADH-ferricyanide, NADH oxidase,
NADPH oxidase and energy-dependent NAD reductase activ-
ities by arylazido-L-alanine ADP-ribose. SMPs (30 Wg/ml) were
activated (see [11]) with 1 WM NADH for 2 min at 25‡C and
irradiated by 320^350 nm light in the presence of 20 WM aryl-
azido-L-alanine ADP-ribose for a time indicated on the ¢gure
(see Section 2). NADH-ferricyanide reductase (R), NADH oxi-
dase (b), NADPH oxidase (8) and succinate-supported NAD
reductase reactions (F) were assayed as described in Section 2.
One hundred percent activities correspond to 9.5 and 1.16 Wmol
NADH oxidized, 0.11 Wmol NADPH oxidized and 0.25 Wmol
NAD reduced per min per mg protein for NADH-ferricyanide
reductase, NADH oxidase, NADPH oxidase and NAD reduc-
tase reactions, respectively. Irradiation of the particles for 2 min
in the presence of 10 mM ADP-ribose did not result in reduc-
tion of either of the above-mentioned enzymatic activities.
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dation at concentrations lower than 50 WM (data not
presented). A higher a⁄nity of arylazido-L-alanine
ADP-ribose compared to that of arylazido-L-alanine
NAD corresponds nicely with the recent data of
Vinogradov and coworkers [9], demonstrating a
high a⁄nity of the ADP-ribose molecule to the active
site of complex I.
Irradiation of SMPs by 320^350 nm light in the
presence of arylazido-L-alanine ADP-ribose causes
time-dependent irreversible inhibition of NADH-fer-
ricyanide activity of complex I (see Fig. 3A). The
photo-dependent inhibition is completely prevented
by ADP-ribose, a competitive inhibitor of the en-
zyme [9]. Protection of the enzyme from photo-inac-
tivation by ADP-ribose supports the competitive na-
ture of the arylazido-L-alanine ADP-ribose-induced
inhibition. The activity of the enzyme decreases ex-
ponentially with the time of irradiation in the pres-
ence of arylazido-L-alanine ADP-ribose. In order to
slow the photo-inactivation process down, the excit-
ation power was reduced eight times with a neutral
density ¢lter. The pseudo-¢rst order rate constant of
inactivation estimated by single exponential ¢tting of
the data on Fig. 3A depends hyperbolically on the
concentration of arylazido-L-alanine ADP-ribose (see
Fig. 3B). The hyperbolic dependence of the inactiva-
tion rate on the inhibitor concentration indicates that
the mechanism of irreversible inhibition of complex I
includes formation of speci¢c reversible complex be-
tween the enzyme’s active center and arylazido-L-ala-
nine ADP-ribose and further light-induced attach-
ment of the inhibitor to the protein. The
dissociation constant of 35 þ 5 WM was estimated
for the enzyme arylazido-L-alanine ADP-ribose com-
plex by hyperbolic analysis of the dependence of the
inhibition rate on the concentration of arylazido-L-
alanine ADP-ribose (see Fig. 3B). This value is equal
within the experimental error to the value of Ki for
reversible inhibition of NADH oxidase activity by
the analogue (see Fig. 2).
Irreversible inhibition of NADH-ferricyanide re-
ductase, NADH oxidase, NADPH oxidase and suc-
cinate-supported NAD reductase activities of the
enzyme by arylazido-L-alanine ADP-ribose is shown
in Fig. 4. As seen in the ¢gure, a ¢nal level of light-
induced inhibition, established during irradiation of
SMPs in the presence of 20 WM arylazido-L-alanine
ADP-ribose, is di¡erent for NADH oxidase,
NADPH oxidase and NAD reductase activities.
The rates of NADH-ferricyanide reductase and
NADH oxidase reactions are reduced by 93^95%,
NAD reductase activity by 65% and NADPH oxi-
dase activity by 50%. Partial inhibition of the reac-
tions is not the result of an insu⁄cient concentration
of the inhibitor. A three-fold increase of the arylaz-
ido-L-alanine ADP-ribose concentration did not re-
Fig. 5. Kinetics of NADH-ubiquinone reductase and succinate-
supported NAD reductase reactions catalyzed by native and
arylazido-L-alanine ADP-ribose-treated SMPs. SMPs were pre-
treated with 2 WM NADH for 2 min at 25‡C and irradiated for
1 min in the presence of 20 WM arylazido-L-alanine ADP-ribose
as shown in Fig. 4. NADH-ubiquinone reductase (A) and
NAD reductase (B) reactions of native (curves 1) and photo-
inactivated SMPs (curve 2) were assayed at di¡erent substrate
concentrations as described in Section 2. Dependences of the in-
itial rates of NADH-ubiquinone reductase and NAD reductase
reactions on the dinucleotide concentration are depicted on the
¢gure. Solid curves correspond to single hyperbolic ¢ts with the
following parameters: Km = 1.0 WM, Vmax = 1.17 Wmol/min mg;
Km = 30 WM, Vmax = 0.16 Wmol/min mg; Km = 37 WM,
Vmax = 0.29 Wmol/min mg; Km = 1.8 mM, Vmax = 0.13 Wmol/min
mg for curves 1 and 2 of A and curves 1 and 2 of B, respec-
tively.
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sult in a stronger inhibition of either of the enzymatic
activities (data not shown). Inactivation of any of the
above-mentioned activities is completely prevented
by ADP-ribose, which is indicative of the competitive
nature of the inhibition.
The residual fraction of the enzyme, left uninhib-
ited after treatment with arylazido-L-alanine ADP-
ribose, is characterized by a low a⁄nity to NADH
and NAD. Km for NADH estimated for the un-
treated enzyme is equal to 1.0 WM, while the value
estimated for the arylazido-L-alanine ADP-ribose-
treated enzyme is equal to 30 WM (see Fig. 5A).
The a⁄nity of NAD to the inhibited and the native
enzyme is signi¢cantly di¡erent as well. Km values for
NAD in NAD reductase reaction catalyzed by
arylazido-L-alanine ADP-ribose-treated and the na-
tive enzyme (see Fig. 5B) are 1.8 mM and 37 WM,
respectively. Kinetic parameters for the arylazido-L-
alanine ADP-ribose-treated and the uninhibited en-
zyme are summarized in Table 1. As evident from
Table 1, the arylazido-L-alanine ADP-ribose-inhib-
ited enzyme catalyzes NAD reductase and NADH
oxidase reactions with similar maximum rates. The
native enzyme is more e⁄cient in catalyzing the di-
rect reaction.
Fig. 6 demonstrates the time-course of NAD re-
duction driven by oxidation of succinate as catalyzed
by uninhibited and arylazido-L-alanine ADP-ribose-
treated SMPs. After oxidation of a small amount of
NADH (the event required for activation of complex
I [11]), succinate and NAD were added simultane-
ously. The rate of NADH accumulation progres-
sively slows down as a result of enzymatic oxidation
of generated NADH. A high a⁄nity of uninhibited
complex I to NADH and a high rate of NADH
oxidation compared to the NAD reduction result
in strong suppression of the reverse reaction even
at low concentrations of accumulated NADH (curve
1 of Fig. 6). The inhibited enzyme characterized by
low a⁄nity to NADH and a low rate of NADH
oxidation (see Table 1) displays almost a linear de-
pendence of product formation in time (curve 2 of
Fig. 6).
4. Discussion
In the present study, we have shown that arylaz-
ido-L-alanine ADP-ribose has a high a⁄nity to the
active center of complex I. In the dark, it acts as a
competitive reversible inhibitor of the enzyme with
Table 1
Catalytic properties of native and arylazido-L-alanine ADP-ribose-inactivated SMPs
Reaction SMPs Inactivated SMPsa
Kbm, WM V
b
max, Wmol/min/mg K
b
m, WM V
b
max, Wmol/min/mg
NADH-ubiquinone reductase 1.0 1.17 30 0.16
NAD reductase 37 0.29 1 800 0.13
aSMPs were irradiated by 320^350 nm light in the presence of 20 WM arylazido-L-alanine ADP-ribose for 1 min as shown in Fig. 4.
bEstimated as shown in Fig. 5.
Fig. 6. Time-course of the succinate-supported NAD reduction
catalyzed by native and arylazido-L-alanine ADP-ribose-inhib-
ited SMPs. Curve 1, SMPs (20 Wg/ml) were pre-incubated with
2 WM NADH in a glass microcuvette ¢lled with 1 ml of the as-
say solution (see Section 2) for 2 min at 25‡C in order to ob-
tain maximum NAD reductase activity. Curve 2, SMPs (60
Wg/ml) were pre-activated with NADH as described above and
irradiated by 320^350 nm light in the presence of 10 WM aryl-
azido-L-alanine ADP-ribose for 1 min as described in Section 2.
The reaction was initiated by simultaneous addition of NAD
(2 mM) and succinate-K (20 mM) to the assay solution.
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Ki value of 37 WM (see Fig. 2). When photo-irradi-
ated, arylazido-L-alanine ADP-ribose causes irrevers-
ible inhibition of the enzyme. Complete protection of
the enzyme from irreversible inactivation by ADP-
ribose (see Fig. 3A) and a hyperbolic dependence
of the inactivation rate on the concentration of aryl-
azido-L-alanine ADP-ribose (see Fig. 3B) indicate
that inactivation of the enzyme proceeds through
formation of a speci¢c complex between the enzy-
me’s active center and the inhibitor. The a⁄nity
binding constant of 35 WM was estimated for aryl-
azido-L-alanine ADP-ribose by analysis of the de-
pendence of the rate of irreversible inhibition on
the concentration of the inhibitor (see Fig. 3B).
The latter value corresponds nicely with the value
of Ki estimated for the reversible inhibition of the
enzyme by arylazido-L-alanine ADP-ribose.
The high a⁄nity of ADP-ribose [9] and its aryl-
azido-L-alanine analogue (present work) to the active
center of complex I compared to that of NAD [7,8]
may be explained by assuming the presence of pos-
itively charged amino acid residue(s) close to the lo-
cation of the nicotinamide group of the dinucleotide
in the active center of complex I. The electrostatic
repulsion between the proposed positively charged
amino acid residue and the oxidized nicotinamide
group may account for a rather low a⁄nity of
NAD to the active center of the enzyme. Elimina-
tion of the nicotinamide’s positive charge either by
NAD reduction or by removing the nicotinamide
group results in a considerable increase of a⁄nity
of the molecule to the enzyme. The two orders of
magnitude higher a⁄nity of NADH [8] and ADP-
ribose [9] to the active center of complex I compared
to that of NAD [7,8] supports the above suggestion.
Photo-irradiation of SMPs in the presence of aryl-
azido-L-alanine ADP-ribose results in incomplete in-
hibition of the enzyme. The rates of NADH-ferricya-
nide reductase and NADH-ubiquinone reductase
reactions are reduced by 93^95%, while NAD re-
ductase activity dropped only by 65%. The a⁄nity of
the arylazido-L-alanine ADP-ribose resistant NADH
oxidase and NAD reductase activities of the en-
zyme to their corresponding substrates are lower
by two orders of magnitude as compared to those
of the uninhibited NADH-ubiquinone reductase
(see Table 1).
Di¡erent sensitivities of the reverse and direct re-
actions catalyzed by complex I to arylazido-L-alanine
ADP-ribose inhibition are consistent with the pro-
posal of two catalytically competent nucleotide-bind-
ing sites on the enzyme. The arylazido-L-alanine
ADP-ribose sensitive site, having a high a⁄nity to
the dinucleotide, is more speci¢c with respect to
NADH oxidation. On the other hand, the arylaz-
ido-L-alanine ADP-ribose insensitive site, having a
low a⁄nity to NAD and NADH, catalyzes the re-
verse and the direct reactions with almost equal max-
imum rates (see Table 1). The di¡erence in sensitiv-
ities of the forward and backward reactions of
complex I to arylazido-L-alanine ADP-ribose is con-
sistent with the observation of Zharova and Vinog-
radov [9] on the unidirectional nature of ADP-ri-
bose-induced inhibition of the enzyme. A strong
competitive inhibition of NADH oxidation by
ADP-ribose and inability of ADP-ribose to suppress
energy-dependent NAD reductase reaction led the
authors to stipulate the existence of two unidirection-
al nucleotide-binding sites on complex I, one catalyz-
ing the direct and another the reverse reaction. Ac-
cording to our data, each of the suggested active sites
is capable of catalyzing both the reverse and the
direct reactions. The relative e⁄ciencies of these sites
in driving NADH oxidation and NAD reduction
are, however, signi¢cantly di¡erent.
Fifty percent reduction of NADPH oxidase activ-
ity by arylazido-L-alanine ADP-ribose demonstrated
in this work is also consistent with the two catalyti-
cally competent nucleotide-binding sites on complex
I, contributing equally to the overall rate of NADPH
oxidation.
A large number of subunits comprising complex I
leaves room for speculations on the location of the
arylazido-L-alanine ADP-ribose sensitive and insen-
sitive sites on the enzyme molecule. Two nucleotide-
binding motifs located on the 51 kDa [13] and on the
39 kDa [1] subunit of complex I may be possible
candidates. A high a⁄nity of arylazido-L-alanine
ADP-ribose enables to selectively label the active
site of complex I and to determine the subunit to
which the inhibitor is attached. These experiments
are underway at present in our laboratory and in-
clude covalent attachment of arylazido-L-alanine
ADP-ribose to the active center of isolated complex
I and subsequent identi¢cation of the labelled sub-
unit.
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